AN Venture Partners

SOURCE

Discover Innovative, Untapped Science in Japan

Discover Innovative, Untapped Science in Japan

BUILD

Building Startups in the US Powered by the World's Largest Biotech Ecosystem

Building Startups in the US Powered by the World's Largest Biotech Ecosystem

FINANCE

Connecting Startups with Leading Global Venture Capitals for Scalable Growth

Connecting Startups with Leading Global Venture Capitals for Scalable Growth

We Build Enduring Value for Our Partners by Globally Advancing Biotech Innovation from Japan

Our Team

A Highly Experienced Core Team Leveraging a Global Network of Experts

Connecting knowledge, capital, and innovation to advance science worldwide.

Team

Ken Horne

Ken Horne smiling

Ken Horne

Managing Partner

Ari Nowacek MD, PHD, MBA

Ari Nowacek MD, PHD, MBA smiling

Ari Nowacek MD, PHD, MBA

Partner (Partner, ARCH Ventures)

Takashi Futami PHD, MBA

Takashi Futami PHD, MBA smiling

Takashi Futami PHD, MBA

Partner

Jun Hashimoto

Jun Hashimoto smiling

Jun Hashimoto

Partner

Atsushi Shimada

Atsushi Shimada smiling

Atsushi Shimada

Senior Principal

Toshikazu Ban

Toshikazu Ban smiling

Toshikazu Ban

Executive Partner

Mike Hickey

Mike Hickey smiling

Mike Hickey

CFO

Masaki Tanaka PHD

Masaki Tanaka PHD smiling

Masaki Tanaka PHD

Investment Manager

Paula Schultheiss PHD

Paula Schultheiss PHD smiling

Paula Schultheiss PHD

Associate

Dai Hata PHD

Dai Hata PHD smiling

Dai Hata PHD

Associate

Shiho Hirose PHD

Shiho Hirose PHD smiling

Shiho Hirose PHD

Analyst

Yumiko Nejo

Yumiko Nejo smiling

Yumiko Nejo

Controller

Olivia Laxton

Olivia Laxton smiling

Olivia Laxton

Fellow

Natsuko Kayashima

Natsuko Kayashima smiling

Natsuko Kayashima

Executive Assistant

Updates from Our Team, in Real Time.

Portfolio

Investing in Startups That Will Shape the Future.

Investing in and celebrating ventures that shape the future.

Capacity Bio is developing a portfolio of small molecule mitophagy inducers.

Capacity Bio is developing a portfolio of small molecule mitophagy inducers. hover

Capacity Bio is developing a portfolio of small molecule mitophagy inducers.

Typewriter Therapeutics is developing an RNA-based gene writing therapeutic platform.

Typewriter Therapeutics is developing an RNA-based gene writing therapeutic platform. hover

Typewriter Therapeutics is developing an RNA-based gene writing therapeutic platform.

City Therapeutics is harnessing next-generation engineering of small interfering RNAs (siRNAs).

City Therapeutics is harnessing next-generation engineering of small interfering RNAs (siRNAs). hover

City Therapeutics is harnessing next-generation engineering of small interfering RNAs (siRNAs).

Imbria is developing novel therapies for patients with life-altering cardiometabolic disorders

Imbria is developing novel therapies for patients with life-altering cardiometabolic disorders hover

Imbria is developing novel therapies for patients with life-altering cardiometabolic disorders

PAhR Therapeutics is developing innovative treatments for Pulmonary Arterial Hypertension.

PAhR Therapeutics is developing innovative treatments for Pulmonary Arterial Hypertension. hover

PAhR Therapeutics is developing innovative treatments for Pulmonary Arterial Hypertension.

Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout

Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout hover

Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout

Stealth Companies

Some portfolio companies are in stealth mode. Updates will be shared in due course.

Press Release

Expert Perspectives on Science, Innovation, and Investment.

Media

Highlighting Our Work Through Media Coverage.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.